We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Postoperative Complications Affect Long-Term Survival

By HospiMedica International staff writers
Posted on 09 Sep 2014
A new study suggests that postoperative in-hospital morbidity not only present a risk to patients in the short term, but may also reduce long-term survival.

Researchers at Imperial College London (United Kingdom) and the University of Pennsylvania (Philadelphia, USA) searched MEDLINE, Web of Science, and reference lists of articles for studies assessing postoperative in-hospital complications and morbidity. More...
Procedure-specific or technical failure-related complications were excluded, as were studies of poor methodological quality. In all, 18 eligible studies involving 134,785 patients with an overall complication rate of 22.6% were included. The studies included operations for both benign and malignant disease.

Meta-analysis demonstrated reduced overall survival after any postoperative complication for ten studies with eligible data (20,755 patients), with a hazard ratio (HR) of 1.28; overall survival following infectious complications showed a HR of 1.92. In analyses of disease-free survival, the HR was 1.26 for all postoperative complications and 1.55 for infectious complications. Inclusion of poor-quality studies in a sensitivity analysis had no effect on the overall results. The study was published on August 29, 2014, in the British Journal of Surgery.

“Postoperative complications have a negative effect on long-term survival; this relationship appears to be stronger for infectious complications,” concluded lead author Philip Pucher, MRCS, and colleagues of the department of surgery and cancer. “The preventable nature of these complications suggests more must be done to improve care and thus enhance survival rates following major surgery.”

Related Links:

Imperial College London
University of Pennsylvania



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.